Search results
Results from the WOW.Com Content Network
Trimix is a combination of three drugs: alprostadil, papaverine, and phentolamine. These medications work in combination to increase blood flow to the penis, resulting in an erection. [1] [2] [3] Alprostadil is a prostaglandin vasodilator that allows more blood to flow into the area by relaxing the smooth muscle in the blood vessels of the penis.
Benign prostatic hyperplasia (BPH), also called prostate enlargement, is a noncancerous increase in size of the prostate gland. [1] Symptoms may include frequent urination, trouble starting to urinate, weak stream, inability to urinate, or loss of bladder control. [1]
An intracavernous (or intracavernosal) injection is an injection into the base of the penis.This injection site is often used to administer medications to check for or treat erectile dysfunction in adult men (in, for example, a combined intracavernous injection and stimulation test). [1]
In these cases, the patients may be prescribed expensive autoimmune disease drugs that just manage the symptoms but don't actually treat the cause, according to the doctor.
An enlarged prostate is common in older men and typically carries symptoms of lower urinary tract problems, which can become bladder problems over time. Tadalafil is typically taken daily for BPH.
[1] [2] Diagnosis is typically based on measuring the amount of urine in the bladder after urinating. [1] Treatment is typically with a catheter either through the urethra or lower abdomen. [1] [3] Other treatments may include medication to decrease the size of the prostate, urethral dilation, a urethral stent, or surgery. [1]
A study confirmed that side effects like pancreatitis and kidney damage are possible while taking GLP-1s like Ozempic. Here's what a doctor wants you to know.
Trimix is self-administered with a tiny needle (31g)that is not much thicker than a hair. and is virtually painless. It takes effect in a few minutes and the erection typically lasts an hour or so. 72.64.38.141 ( talk ) 00:06, 26 August 2008 (UTC) [ reply ]